Patents Assigned to Norwell, Inc.
  • Patent number: 10076562
    Abstract: Provided herein are methods for using compositions that include a fusion protein having a YscF protein domain, a mature F1 protein domain, and a LcrV protein domain. In one embodiment the composition is used to confer immunity to plague, such as pneumonic plague, caused by Yersinia pestis. In one embodiment, the composition is administered to a mucosal surface, such as by an intranasal route. In one embodiment, the administration to a mucosal surface includes a vector that has a polynucleotide encoding a fusion protein, where the fusion protein includes a YscF protein domain, a mature F1 protein domain, and a LcrV protein domain. The administration is followed by a second administration by a different route, such as an intramuscular route. The second administration includes a fusion protein having the same three domains, and in one embodiment the fusion protein is the same one administered to a mucosal surface.
    Type: Grant
    Filed: April 18, 2017
    Date of Patent: September 18, 2018
    Assignees: The Board of Regents of the University of Texas System, Norwell, Inc.
    Inventors: Ashok K. Chopra, Vladimir L. Motin, Eric Rothe
  • Patent number: D540596
    Type: Grant
    Filed: May 9, 2005
    Date of Patent: April 17, 2007
    Assignee: Norwell, Inc.
    Inventor: Edward Benjamin Duggan
  • Patent number: D552290
    Type: Grant
    Filed: May 9, 2005
    Date of Patent: October 2, 2007
    Assignee: Norwell, Inc.
    Inventor: Edward Benjamin Duggan